Private Diabetes & HbA1c Test UK (2026): Cost, Providers, What to Test
Short version: HbA1c is the right first test for diabetes screening or pre-diabetes investigation in the UK. Standalone HbA1c fingerprick costs £19 from Medichecks; a proper diabetes profile (HbA1c + lipids + liver + kidney) £45–£89. UK diagnostic thresholds: under 42 mmol/mol normal, 42–47 pre-diabetes (high-risk), 48+ diabetes. Take a positive result to your GP — diabetes is a clinical diagnosis with ongoing care needs, not a one-off lab result.
Type 2 diabetes affects roughly 1 in 14 UK adults, with pre-diabetes affecting around 1 in 8. Both are rising. Both are diagnosable from a single £19 home blood test — and yet a substantial fraction of UK pre-diabetes goes undiagnosed because adults under 40 are rarely screened on the NHS unless they have specific risk factors. Private testing fills a real gap here. This guide walks through what to test, what the numbers mean, what the NHS will and won't do, and the practical decisions that follow a positive result.
Who should consider private HbA1c testing
Six scenarios where private diabetes screening makes sense:
- You are under 40 with raised BMI, family history of type 2 diabetes, or higher-risk ethnicity (South Asian, Black African, Black Caribbean, Middle Eastern). NHS Health Check screening doesn't start until 40 in most areas. Private screening earlier is meaningfully useful.
- You have symptoms that could be early diabetes — unexplained tiredness, increased thirst or urination, recurrent infections, slow-healing wounds, mild blurred vision. Same-week private testing rules in or out quickly.
- You have PCOS, gestational diabetes history, or have been on long-term steroids. All meaningfully raise type 2 diabetes risk and warrant earlier or more frequent screening than the NHS standard.
- You are 40+ and your last NHS Health Check was a while ago (or you've never had one). HbA1c every 1–3 years from 40 onward is reasonable practice for most adults.
- You have a known pre-diabetic HbA1c and want to track response to lifestyle change. NHS practice is annual retesting; private testing can sit between to track progress more closely.
- You're on a low-carb or Mediterranean dietary intervention for metabolic health. HbA1c every 12–24 weeks is the standard objective measure of progress.
HbA1c thresholds: what the numbers mean
UK NICE-endorsed HbA1c categories:
| HbA1c (mmol/mol) | Equivalent (%) | Category | What it means |
|---|---|---|---|
| <42 | <6.0% | Normal | Low diabetes risk. Retest based on risk profile. |
| 42–47 | 6.0–6.4% | Pre-diabetes (NDH) | Substantially raised risk of progression. Lifestyle change indicated. Annual retest. |
| 48–58 | 6.5–7.5% | Type 2 diabetes (likely) | Diabetes range. Confirm with second test or symptoms. GP review essential. |
| 59–86 | 7.6–10.0% | Poorly controlled diabetes | Above NHS target for most patients. Treatment intensification typically needed. |
| >86 | >10.0% | Severe hyperglycaemia | Urgent GP/specialist input. Risk of complications high. |
Two important caveats. First, HbA1c around the 48 mmol/mol threshold should not be treated as a binary — 47 and 49 are essentially the same biological state. The threshold is operationally useful but biologically arbitrary. Second, a single raised HbA1c is a screening flag, not a confirmed diagnosis. UK diagnostic practice requires a second confirmatory test, or symptoms alongside the raised result. The conversation with your GP is part of the diagnosis, not optional follow-up.
What to test beyond HbA1c
The core screen
- HbA1c — the headline. 8–12 week glucose average. Non-fasted. The right first-line test.
- Fasting glucose — useful confirmatory marker. Requires 8-hour fast. Diagnostic threshold for diabetes is 7.0 mmol/L or above.
- Lipid profile (total cholesterol, HDL, LDL, non-HDL, triglycerides) — diabetes is part of a metabolic risk cluster. Lipids should always be measured alongside.
- ALT (alanine aminotransferase) — fatty liver disease (now called MASLD) commonly accompanies pre-diabetes and is independently important.
- eGFR / creatinine — kidney function baseline, important if diabetes is confirmed because kidney monitoring becomes part of ongoing care.
Useful additions for fuller metabolic picture
- TSH — thyroid dysfunction can mimic and overlap with metabolic symptoms.
- Fasting insulin + HOMA-IR — calculated insulin resistance index. Useful for early-stage metabolic dysfunction before HbA1c rises. Found in "comprehensive" panels at £79+.
- Apolipoprotein B (ApoB) — better cardiovascular risk marker than LDL in insulin resistance.
- hsCRP — chronic low-grade inflammation marker; tracks metabolic health.
- Vitamin D, magnesium — relevant in metabolic optimisation; deficiencies common.
Skip these unless specifically indicated
- C-peptide, GAD antibodies, IA-2 antibodies — useful for distinguishing type 1 from type 2 diabetes in unclear cases. Standard private screening doesn't need these.
- Continuous glucose monitoring (CGM) for asymptomatic non-diabetic screening — currently popular among "metabolic health" enthusiasts but the actionable information for normal HbA1c individuals is limited. CGM is genuinely useful in diabetes management, less clearly so in healthy adults.
UK private diabetes test costs in 2026
| Panel tier | What's in it | Typical UK price |
|---|---|---|
| HbA1c only | HbA1c, fingerprick | £19–£39 |
| Basic diabetes profile | + fasting glucose, lipids | £35–£59 |
| Diabetes + metabolic | + ALT, eGFR, TSH | £49–£89 |
| Comprehensive metabolic | + insulin, HOMA-IR, ApoB, hsCRP | £79–£149 |
| In-clinic health check | Above + vitals, weight, BP | £150–£350 |
The labs worth considering
Medichecks — Medichecks HbA1c at £19 is the cheapest UKAS-accredited UK option for standalone HbA1c. Their Diabetes Profile at around £49 covers HbA1c plus the rest of the core screen. Fingerprick home kits, doctor's report included.
Thriva — Thriva's Metabolic Health panel sits around £69 and adds their app-based tracking — useful for those who want to monitor trends over multiple tests. Higher base price than Medichecks but the longitudinal tooling has real value.
Forth — Forth Metabolic Health at around £89 is the most comprehensive UK home metabolic panel widely available, including insulin and HOMA-IR. Worth the premium if you want one test that covers everything; overkill if you just want HbA1c.
What to do after a positive result
Pre-diabetes range (42–47 mmol/mol)
- Don't panic. Pre-diabetes is reversible in 30–50% of cases through lifestyle change. This is the most actionable result you can get on a blood test.
- Take the result to your GP. Tell them the result and ask for repeat NHS testing for confirmation, plus referral to the NHS Diabetes Prevention Programme (DPP) in England. The DPP is free, evidence-based, and shows ~30% reduction in progression to type 2 diabetes.
- Make the lifestyle changes that work. 5–10% weight loss if overweight. 150 minutes/week of moderate-intensity activity. Dietary modification — Mediterranean-style or low-carbohydrate approaches both have good evidence. Sleep and stress management.
- Retest HbA1c at 12 weeks to see if changes are working. Then every 6–12 months.
Diabetes range (≥48 mmol/mol)
- See your GP this week. Type 2 diabetes is a clinical diagnosis with ongoing care needs — not a result to manage alone with another private test in 3 months.
- NHS will repeat the test and assess for symptoms. Diagnosis confirmed triggers the NHS diabetes care pathway: HbA1c monitoring every 3–6 months, blood pressure, kidney function, eye screening, foot checks, dietary support, treatment as needed.
- Lifestyle is still the foundation. Many patients with HbA1c in the 48–58 mmol/mol range achieve sustained reduction below 48 through diet and weight loss alone, particularly with low-carbohydrate or Mediterranean approaches. Type 2 diabetes remission is a recognised clinical outcome.
- Medication if needed. Metformin is first-line. GLP-1 receptor agonists (semaglutide, etc.) are increasingly used for weight loss and glycaemic control together. Discuss with your GP based on your overall picture.
A note on CGM and the "metabolic health" market
Continuous glucose monitors — Abbott Libre, Dexcom — have become popular among non-diabetic adults interested in metabolic optimisation, often via subscription services like Levels or ZOE. Worth being clear-eyed about this:
- For diagnosed diabetes: CGM is a genuine clinical advance. UK NHS now funds CGM for many type 1 diabetes patients and an expanding subset of type 2.
- For pre-diabetes: 2-week CGM can provide useful behavioural feedback (you see which meals spike you) but its long-term benefit over HbA1c-based monitoring is not well-established.
- For non-diabetic adults with normal HbA1c: CGM use is controversial. Most clinical opinion is that "post-meal spikes" in normal adults are physiological and don't warrant intervention. The behavioural intervention may still drive useful dietary changes, but it is not lab-validated medical screening.
If you are starting from "is my HbA1c okay?", a £19 fingerprick HbA1c gives you the answer cheaper, faster and more relevantly than two weeks of CGM at £150+.
Related guides
- Private blood tests UK — pillar guide — the complete UK private testing playbook.
- Cardiovascular risk test UK — the diabetes–ASCVD axis; ApoB and Lp(a) for advanced lipid risk.
- Liver health blood test UK — MASLD (fatty liver) sits directly on the diabetes–metabolic spectrum.
- Private B12 & folate blood test UK — metformin reduces B12 absorption; annual monitoring recommended.
- HbA1c test deep-dive — the science of glycated haemoglobin.
- Cholesterol & lipid panel guide — pair with HbA1c for cardiovascular risk.
- Best blood test for weight loss and metabolic health — broader umbrella guide.
- Liver function test deep-dive — marker science behind the liver buyer guide.
- Private blood test vs NHS — the wider decision frame.
- How to choose a private blood test in the UK — buyer's guide.